David P. Hochman - Jul 20, 2023 Form 4 Insider Report for Orchestra BioMed Holdings, Inc. (OBIO)

Role
Chief Executive Officer and Chairperson, Director
Signature
/s/ Matthew R. Schob, Attorney-in-Fact
Stock symbol
OBIO
Transactions as of
Jul 20, 2023
Transactions value $
$0
Form type
4
Date filed
7/24/2023, 05:13 PM
Previous filing
May 5, 2023
Next filing
May 10, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OBIO Common Stock, par value $0.0001 per share ("Common Stock") Award $0 +300K +181.27% $0.00 465K Jul 20, 2023 Direct F1
transaction OBIO Common Stock Award $0 +165K +263.99% $0.00 228K Jul 20, 2023 By the DPH 2008 Trust F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OBIO Stock Option (Right to Buy) Award $0 +101K $0.00 101K Jul 20, 2023 Common Stock 101K $7.42 Direct F2
transaction OBIO Stock Option (Right to Buy) Award $0 +132K $0.00 132K Jul 20, 2023 Common Stock 132K $7.42 By the DPH 2008 Trust F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents an award of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Common Stock. The RSUs vest over a three-year period as follows: (i) 34% of the shares will vest on the 18-month anniversary of January 26, 2023 (the "Vesting Commencement Date"), (ii) 33% the shares will vest on the two-year anniversary of the Vesting Commencement Date, and (iii) 33% the shares will vest on the three-year anniversary of the Vesting Commencement Date, subject to the Reporting Person's continuous service through such dates.
F2 The stock options vest over a four-year period as follows: (i) 25% of the underlying shares will vest on the one-year anniversary of the Vesting Commencement Date and (ii) 75% of the underlying shares will vest in equal installments on a quarterly basis on the last day of each quarter, starting on the last day of the first quarter after the first anniversary of the Vesting Commencement Date, or March 31, 2024, subject to the Reporting Person's continuous service through such dates.

Remarks:

Chief Executive Officer and Chairperson